RESUMO
Dense metallic membranes, especially Pd and Pd alloys, have been intensely investigated to provide an alternative and economical way to obtain H2 with ultrahigh purity. To overcome the high cost of Pd, composite membrane structures that comprise a thin layer of Pd are utilized. However, it is a challenge to obtain a thin, dense, and uniform Pd layer on the support materials. This study investigates the parametric analysis of γ-Al2O3 interlayer formation and the electroless Pd plating (Pd ELP) procedures on α-Al2O3 supports with the aim to achieve a thin, uniform Pd surface without annealing. Adjustments in PEG/PVA concentration, dipping time, and heat treatment enabled creating a thin γ-Al2O3 interlayer on α-Al2O3, minimizing pore size and density. Hydrazine concentration, heat treatment, and bath temperature were adjusted to optimize Pd ELP to achieve maximum yield from the plating bath and a dense, uniform surface without annealing. Pd/γ-Al2O3/α-Al2O3 structures were analyzed using scanning electron microscopy, X-ray diffraction, and thermogravimetric analysis to observe the impact of varied parameters on surface structures. Optimized sample was compared to an annealed Pd/α-Al2O3 prepared in accordance with literature methods and a Pd/graphite/α-Al2O3 sample to validate the use of optimized ELP procedure and the γ-Al2O3 interlayer. Results show that a dense and uniform 13 µm Pd coating was achieved on a γ-Al2O3-coated α-Al2O3 support without annealing, using three fresh ELP baths. This was done using sequential hydrazine addition with a decreased concentration (1 M) into the ELP baths at 30 °C, and applying heat treatment at 120 °C between each fresh ELP bath.
RESUMO
INTRODUCTION: Stroke-like migraine attacks after radiation therapy (SMART) syndrome, is a late complication of brain radiotherapy (1). Symptoms are commonly subacute in onset and involve migraine type of headache, seizures, focal neurologic deficits (2). Magnetic resonance imaging (MRI) findings are usually unilateral and posterior predominant cortical-subcortical hyperintensity, swelling and prominent gyriform (cortical and leptomeningeal) gadolinium enhancement in the areas of the brain that underwent irradiation with or without diffusion restriction (1). There is no standard treatment protocol for SMART syndrome. Antiepileptics and corticosteroids are commonly used drugs. CASE REPORT: A 65 years old woman was diagnosed with breast cancer with brain metastases and treated with more than 50 Gy brain radiotherapy. The patient presented with acute right-sided weakness and numbness, episodic myoclonic jerking of the right arm and leg, and gait instability five months later. MRI and magnetic resonance angiography of the brain with gadolinium revealed left parietooccipital cortical diffusion restriction and accompanying dilatation of the left posterior cerebral artery as new findings. Computed tomography (CT) perfusion revealed increased perfusion in the affected area. The patient was diagnosed with SMART syndrome. MANAGEMENT AND OUTCOME: The patient was treated with dexamethasone (16 mg/day) and anticonvulsant therapy. Myoclonic seizures had almost completely remitted. However, her cognitive impairment persisted, then the patient was arrested because of aspiration a month later. DISCUSSION: Besides confirming SMART syndrome, diagnostic investigations are also important to exclude other etiologies. Posterior reversible encephalopathy syndrome, post-ictal changes, meningoencephalitis, and cerebrovascular diseases are radiological differential diagnoses considered (3). Proper and early diagnosis of SMART syndrome is significant in preventing unnecessary aggressive approaches and appropriate treatment to avoid lesions of sequela.
